Pharmacognosy Department, University of Sana'a, Pharmacy College, Sanaa, Yemen.
Department of Forensic Medicine and Clinical Toxicology, College of Medicine, Sana'a University, Sanaa, Yemen.
Chem Biodivers. 2024 Oct;21(10):e202400707. doi: 10.1002/cbdv.202400707. Epub 2024 Sep 16.
The study aimed to conduct chemical profiling, acute in-vivo toxicity evaluation, and the potential anti-diabetic effect of standardized Aloe sabaea flowers ethanolic extracts (ASFEE) on alloxan-induced diabetic rats. The chemical composition was analyzed using GC-MS and TLC techniques. The oral acute toxicity study was performed according to the WHO 2000 and the OECD 420 guidelines. Furthermore, anti-diabetic activity was investigated using two doses of ASFEE (0.2 and 0.5 g/kg/day BW, p.o.) compared with glibenclamide (5 mg/kg/day, p.o.). A molecular docking investigation of the identified components with the PTPN9 enzyme was performed to figure out the proposed anti-diabetic mechanism. GC-MS analysis displayed the existence of 18 compounds; most of the compounds were fatty acids and their esters, and phytosterols. Total phenolic and flavonoid contents were 42.00±1.26 mg GAE/g DW and 22.21±1.55 mg QE/g DW, respectively. The results of the in-vivo toxicity study revealed the absence of noticeable signs of toxicity or mortality at various doses establishing the safety of the tested extract. The estimated LD value was higher than 10 g/kg. Antidiabetic action exhibited a noticeable decline in fasting blood glucose (FBG) levels comparable to glibenclamide with no inducing intense hypoglycemia and considerable excess weight.
本研究旨在对索氏菝葜花乙醇提取物(ASFEE)进行化学成分分析、急性体内毒性评价及潜在的抗糖尿病作用研究,采用 GC-MS 和 TLC 技术分析其化学成分。根据世界卫生组织(WHO)2000 年和经合组织(OECD)420 指南进行口服急性毒性研究。此外,通过两种剂量的 ASFEE(0.2 和 0.5 g/kg/天 BW,po)与格列本脲(5 mg/kg/天,po)进行比较,研究抗糖尿病活性。通过与 PTPN9 酶的分子对接研究鉴定出的成分,以了解拟议的抗糖尿病机制。GC-MS 分析显示存在 18 种化合物;大多数化合物为脂肪酸及其酯类和植物甾醇。总酚和总黄酮含量分别为 42.00±1.26 mg GAE/g DW 和 22.21±1.55 mg QE/g DW。体内毒性研究结果表明,在不同剂量下未观察到明显的毒性或死亡率迹象,证明了所测试提取物的安全性。估计的 LD 值高于 10 g/kg。抗糖尿病作用表现为空腹血糖(FBG)水平明显下降,与格列本脲相当,且无诱导严重低血糖和显著体重增加。